branded generics market expected to grow at a cagr of 7.3% through 2026

Download Branded Generics Market expected to grow at a CAGR of 7.3% through 2026

Post on 24-Jan-2018



Health & Medicine

1 download

Embed Size (px)


  • Branded Generics Market: Global Industry Analysis and Opportunity Assessment 2016-2026

    May 2017

    2015 Future Market Insights, All Rights Reserved

    Report Id : REP-GB-1260Status : Jan-2017

    Category : Healthcare, Pharmaceuticals & Medical Devices

  • AboutFuture Market Insights

    2015 Future Market Insights, All Rights Reserved

    Future Market Insights (FMI) is a premier provider of syndicated research reports, customresearch reports, and consulting services. We deliver a complete packaged solution, whichcombines current market intelligence, statistical anecdotes, technology inputs, valuable growthinsights, aerial view of the competitive framework, and future market trends.

    We provide research services at a global as well as regional level; key regions include GCC,ASEAN, and BRIC.

    Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,Technology, Healthcare, and Retail.

    We have a global presence with delivery centers across India specializing in providing globalresearch reports and country research reports. FMI is headquartered out of London, U.K., with astate-of-the-art delivery center located in Pune, India. We combine our knowledge and learningfrom every corner of the world to distill it to one thing the perfect solution for our client.

    Research Capabilities

    Subscription Information

    Customized Research Syndicated Research Investment Research Social Media Research

    Sector Coverage

    Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment

    Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas

    For detailed subscription information please contact

    Hari. T (Sr. Manager - Global Business Development)

    T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268








    Social Media



  • Research Methodology (1/2)

    Systematic Research Approach

    In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.

    PMR formulates a detailed discussion guide to conduct expert and industry interviews

    PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts

    PMR conducts interviews with industry experts, industry players, distributors and retailers

    Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data

    Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry

    PMR delivers industry insights and information in the required format (PDF)

    Data Collection

    Data Filter& Analysis

    Research &Intelligence






    Primary Research

    Company Analysis

    Desk Research

    Identifying key opinion leaders

    Questionnaire design

    In-depth interviews

    Coverage across value chain

    Market participants

    Key strengths

    Product portfolio

    Mapping as per value chain

    Key focus segments

    Key industry experts

    Channel study


    Market dynamics




    Primary Research #

    Linkedin Zoominfo Salesforce Avention

    Factiva GBI Genios Meltwater

    Company websites Company annual

    reports White papers Financial reports

    2015 Future Market Insights, All Rights Reserved

    Secondary Research # Paid Publications#


    Market profiling

    Formulating discussion guide

    Developing list of respondents

    Data analysis

    Data validation

    Data collection








    # includes sources of databases


  • Global Sales of Branded Generics Will Amass More Than US$ 400 Billion in Revenues By 2026-End

    A recent research conducted by Future Market Insights predicts that the global market for brandedgenerics will witness a steady growth in terms of revenues. Over a ten-year forecast period from 2016 to2026, the size of global branded generics market has been estimated to expand at a steady CAGR of 7.3%.Brand-name prescriptions will continue to be ubiquitous among aged people in the world, and sincegeriatric demographics account for a large portion of global drug-consuming population, demand forbranded generics will also rise substantially. In 2016, the global branded generics market has beenvalued at nearly US$ 200 billion, and is projected to reach US$ 413.8 Bn market value by the end offorecast period.

    Some of the leading manufacturers of branded generics are based in Asian countries, and are extendingtheir production capacity to keep up with the surging global depend. In Asia-Pacific excluding Japan(APEJ) region, about US$ 150 billion revenues are expected to be procured by the end of 2026. Duringthe forecast period, branded generics market in the APEJ region will attain fastest growth, registering a10% CAGR, contributing over 35% of global branded generics revenues. North America, Eastern Europeand Latin America are also expected to be lucrative for growth of branded generics sales, while revenuesin Western Europe, Japan and Middle East & Africa (MEA) are likely to incur a considerable dip by 2026-end.

    Branded Generics Market

    2015 Future Market Insights, All Rights Reserved 4

  • Competitive Timeline in Global Branded Generics Market

    Since 2015, Abbott Laboratories, a leading drugmaker in the global pharmaceuticals industry, hasaimed at capitalizing from branded generics businesses in developing regions.

    Teva Pharmaceuticals acquired Allergans branded generics vertical, while Pfizer Inc. bought HospiraInc. both acquisitions have been strategically carried out for repositioning market standings of Tevaand Pfizer respectively.

    In December 2016, India-based Sun Pharmaceuticals Industries Ltd. agreed to buy Swiss drugmakerNovartis AGs branded generics portfolio on cancer medications.

    Another leading branded generics manufacturer, Mylan N.V. recently launched anti-allergy deviceswhich are expected to be half the price of its branded EpiPens.

    Other prominent companies partaking in the growth of global branded generics market include, AspenPharmacare Holding Ltd. and Valeant Pharmaceuticals International, Inc.

    Research Highlights on Global Branded Generics Market

    The report includes a segmental analysis of the global branded generics market, fragmenting its growthon the type of drug formulation, major drug classes, therapeutic applications, and distribution channels.

    Branded Generics Market

    2015 Future Market Insights, All Rights Reserved 5

  • Based on such segmentation, some of the key findings compiled in the report are:

    Nearly three-fifth of the global branded generics revenues estimated in 2016 are expected to beaccounted by oral-type formulations, with parenteral, topic and other formulation types collectivelyaccounting for 8% market value share.

    Hospital pharmacies & retail pharmacies will remain as the largest distribution channels for brandedgenerics throughout the globe.

    In 2016 and beyond, the demand for branded generics in therapeutic treatment of cardiovasculardiseases will be significant, revenues from which are expected to increase at more than 8% CAGR overthe forecast period.

    Global revenues of branded generics accounted by anti-hypertensive drug class are predicted tosurpass US$ 25 billion by 2026-end.

    Branded Generics Market

    2015 Future Market Insights, All Rights Reserved 6

  • 2015 Future Market Insights, All Rights Reserved

    Table of Content

    1. Executive Summary

    2. Market Introduction

    2.1. Market Definition2.2. Market Taxonomy2.3. Generics Market Overview

    3. Global Branded Generics Market Analysis Scenario

    3.1. Market Size (US$ Mn) and Forecast3.1.1. Market Size and Y-o-Y Growth3.1.2. Absolute $ Opportunity

    3.2. Market Overview3.2.1. Value Chain

    4. Market Dynamics

    4.1. Macro-economic Factors4.2. Drivers

    4.2.1. Supply Side4.2.2. Demand Side


  • 2015 Future Market Insights, All Rights Reserved

    Table of Content

    4.3. Restraints4.4. Opportunity4.5. Forecast Factors Relevance and Impact4.7.Regulations4.8.Porter Five Forces Model4.9.Patennt expiries in 2016

    5. Global Branded Generics Market Analysis and Forecasts, By Therapeutic Application Type

    5.1. Introduction5.2. Basis Point Share (BPS) Analysis By Therapeutic Application Type5.3. Y-o-Y Growth Projections By Therapeutic Application Type5.4. Market Value Forecast By Therapeutic Application Type , 20162026

    5.4.1. Oncology5.4.2. Cardiovascular Diseases5.4.3. Diabetes5.4.4. Neurology5.4.5. Gastrointestinal Diseases5.4.6. Dermatology Di eases5.4.7. Analgesics and Anti-inflammatory5.4.8. Others


  • 2015 Future Market Insights, All Rights Reserved

    Table of Content

    5.5. Prominent Trends5.6. Market Attractiveness By Therapeutic Application Type

    6. Global Branded Generics Market Analysis and Forecasts, By Distribution Channel6.1. Introduction6.2. Basis Point Share (BPS) Analysis By Distribution Channel6.3. Y-o-Y Growth Projections By Distribution Channel6.4. Market Value Forecast By Distribution Channel, 20162026